Hong Kong Life Sciences and Technologies Group Limited announced unaudited consolidated earnings results for the third quarter ended December 31, 2019. For the third quarter, the company announced sales was HKD 41.807 million compared to HKD 42.853 million a year ago. Net loss was HKD 9.476 million compared to HKD 3.308 a year ago. Basic loss per share was 0.17 HKD cents compared to 0.05 HKD cents a year ago. For the nine months, sales was HKD 127.228 million compared to HKD 55.889 million a year ago. Net loss was HKD 24.909 million compared to net income of HKD 370,000 a year ago. Basic loss per share was 0.44 HKD cents compared to basic earnings per share of 0.01 HKD cents a year ago.